SII Investments’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
– Sell
-3,178
Closed -$236K – 626
2017
Q2
$236K Sell
3,178
-614
-16% -$43.5K 0.01% 513
2017
Q1
$252K Sell
3,792
-194
-5% -$12.9K 0.02% 513
2016
Q4
$258K Sell
3,986
-250
-6% -$16.2K 0.02% 481
2016
Q3
$301K Sell
4,236
-1,278
-23% -$93.1K 0.02% 419
2016
Q2
$405K Sell
5,514
-776
-12% -$53.6K 0.03% 365
2016
Q1
$406K Buy
6,290
+1,565
+33% +$106K 0.04% 362
2015
Q4
$366K Buy
4,725
+842
+22% +$66.9K 0.05% 310
2015
Q3
$319K Buy
3,883
+477
+14% +$42.5K 0.04% 383
2015
Q2
$302K Buy
3,406
+46
+1% +$4.22K 0.04% 391
2015
Q1
$298K Buy
3,360
+50
+2% +$4.43K 0.04% 401
2014
Q4
$273K Buy
3,310
+13
+0.4% +$1.08K 0.04% 392
2014
Q3
$274K Sell
3,297
-82
-2% -$6.63K 0.04% 377
2014
Q2
$271K Buy
3,379
+77
+2% +$6.06K 0.04% 372
2014
Q1
$236K Buy
3,302
+13
+0.4% +$947 0.04% 357
2013
Q4
$236K Buy
3,289
+236
+8% +$16.4K 0.04% 367
2013
Q3
$214K Buy
+3,053
New +$202K 0.05% 300

Other funds holding NVS

SII Investments's NVS Position: Q3 2017 in Review

SII Investments sold out of Novartis (NVS) in Q3 2017, closing a stake of 3,178 shares — an estimated $236K sold.

SII Investments first reported a position in NVS in Q3 2013 and held it in 16 quarters. The position peaked at $406K in Q1 2016. 938 funds tracked by Wall St. Rank hold NVS as of Q3 2017.

  • SII Investments reported no remaining Novartis position as of Q3 2017 after selling out during the quarter.
  • SII Investments sold 3,178 Novartis shares in Q3 2017, an estimated $236K.
  • SII Investments first reported a position in Novartis in Q3 2013 and held it in 16 quarters.
  • SII Investments's Novartis position peaked at $406K in Q1 2016.
  • 938 funds tracked by Wall St. Rank held Novartis as of Q3 2017.

Based on SII Investments's 13F filing for Q3 2017, filed 13 Nov 2017.